论文部分内容阅读
目的:减少中晚期胃、结直肠恶性肿瘤术后腹腔内复发和肝脏转移率。方法:将143例患者随机分成腹腔化疗组(观察组)70例,静脉化疗组(对照组)73例。结果:观察组与对照组相比,术后腹腔内复发例数4/18,x2=9.85,p<0.005,肝转移例数1/10,x2=7.58,p<0.005,近期死亡例数2/10,x2=16.53,p<0.005,三年以上存活21/11,x2=4.59,p<0.05。结论:对该类患者术后采用5-Fu+MMC腹腔化疗在减少腹腔内复发和肝脏转移方面,近期优于静脉化疗。
Objective: To reduce postoperative intra-abdominal recurrence and liver metastasis of advanced gastric cancer and colorectal cancer. Methods: 143 patients were randomly divided into intraperitoneal chemotherapy group (observation group) 70 cases, intravenous chemotherapy group (control group) 73 cases. Results: Compared with the control group, the number of intra-abdominal recurrence in the observation group was 4/18, x2 = 9.85, p <0.005, the number of hepatic metastasis was 1/10, x2 = 7.58, p <0.005, /10,x2=16.53,p<0.005, survived more than three years 21/11, x2 = 4.59, p <0.05. CONCLUSIONS: The use of 5-Fu + MMC intraperitoneal chemotherapy in these patients is better than intravenous chemotherapy in reducing intraperitoneal recurrence and liver metastasis.